{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:11:28Z","timestamp":1790813488739,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office","doi-asserted-by":"crossref","award":["OTKA-108518"],"award-info":[{"award-number":["OTKA-108518"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejps.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T19:09:02Z","timestamp":1468696142000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Biological evaluation and molecular docking studies of AA3052, a compound containing a \u03bc-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu-NH2, a substance P analogue"],"prefix":"10.1016","volume":"93","author":[{"given":"Agnieszka","family":"Kowalczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Kleczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"R\u0119kawek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Erdei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Borics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej W.","family":"Lipkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Benyhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Makulska-Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bujalska-Zadrozny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.07.009_bb0005","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1523\/JNEUROSCI.20-11-04345.2000","article-title":"Mu-opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn","volume":"20","author":"Aicher","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0031-9384(98)00246-7","article-title":"The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test","volume":"66","author":"Altier","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejps.2016.07.009_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(85)90153-4","article-title":"Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability","volume":"15","author":"Banks","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejps.2016.07.009_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0304-4165(86)90268-0","article-title":"Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M","volume":"882","author":"Bausback","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2016.07.009_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.pa.19.040179.001333","article-title":"Biology of opioid peptides","volume":"19","author":"Beaumont","year":"1979","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<249::AID-JNR7>3.0.CO;2-F","article-title":"Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain","volume":"48","author":"Benyhe","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0035","series-title":"Vasopressin: Principles and Properties","author":"Boer","year":"2012"},{"key":"10.1016\/j.ejps.2016.07.009_bb0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jmgm.2009.11.006","article-title":"Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity","volume":"28","author":"Borics","year":"2010","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejps.2016.07.009_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0166-2236(79)90039-0","article-title":"Bombesin \u2013 a putative mammalian gastrointestinal peptide","volume":"2","author":"Brown","year":"1979","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0143-4179(92)90115-D","article-title":"The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn oft he rat spinal cord","volume":"23","author":"Chapman","year":"1992","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejps.2016.07.009_bb0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/bja\/aer063","article-title":"Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats","volume":"106","author":"Chu","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejps.2016.07.009_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00002512-199405020-00005","article-title":"Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition","volume":"5","author":"Coull","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejps.2016.07.009_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(88)90579-3","article-title":"Facilitation of the tail-flick reflex by noxious cutaneous stimulation in the rat: antagonism by a substance P analogue","volume":"462","author":"Cridland","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0070","article-title":"\u03b12 adrenoreceptor: a target for neuropathic pain treatment","author":"Di Cesare Mannelli","year":"2016","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0075","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/jm0155897","article-title":"Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics","volume":"45","author":"Eguchi","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-3565(24)39016-0","article-title":"Inhibition of morphine tolerance development by a substance P-opioid peptide chimera","volume":"295","author":"Foran","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0085","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1073\/pnas.130181897","article-title":"A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic","volume":"97","author":"Foran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.07.009_bb0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/prot.340230412","article-title":"Knowledge-based protein secondary structure assignment","volume":"23","author":"Frishman","year":"1995","journal-title":"Proteins"},{"key":"10.1016\/j.ejps.2016.07.009_bb0095","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/cmdc.201100169","article-title":"The inverse type II \u03b2-turn on d-Trp-Phe, a pharmacophoric motif for MOR agonists","volume":"6","author":"Gentilucci","year":"2011","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nrd913","article-title":"G protein-coupled receptor oligomerization and its potential for drug discovery","volume":"1","author":"George","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2016.07.009_bb0105","first-page":"51","article-title":"Role of striato-nigral substance P in the regulation oft he activity of the nigro-striatal dopaminergic neurons","volume":"22","author":"Glowinski","year":"1980","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0110","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jps.10202","article-title":"Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin-2","volume":"91","author":"Hau","year":"2002","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0028-3908(86)90233-9","article-title":"Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog","volume":"25","author":"Hayes","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2016.07.009_bb0120","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/art.20184","article-title":"Antiinflammatory and analgesic effect of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat","volume":"50","author":"Helyes","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejps.2016.07.009_bb0125","series-title":"Substance P in the Nervous System","first-page":"206","article-title":"Relation of Substance P to pain transmission: neurophysiological evidence","author":"Henry","year":"1982"},{"key":"10.1016\/j.ejps.2016.07.009_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/endo-107-1-256","article-title":"Effects of substance P on the release of somatostatin, insulin, and glucogon in vitro","volume":"107","author":"Hermansen","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejps.2016.07.009_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(03)01532-2","article-title":"The contribution of alpha2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats","volume":"465","author":"Herrad\u00f3n","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0140","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1063\/1.1683075","article-title":"Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew","volume":"120","author":"Horn","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2016.07.009_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/0253-7613.84969","article-title":"The effect of chronic administration of l-arginine and L-NAME on morphine-induced antinociception in ovariectomized rats","volume":"43","author":"Hosseini","year":"2011","journal-title":"Indian J. Pharm."},{"issue":"524","key":"10.1016\/j.ejps.2016.07.009_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u03bc-opioid receptor activation","volume":"2015","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2016.07.009_bb9000","series-title":"Substance P in the Nervous System","first-page":"307","article-title":"Behavioral effects of substance P through dopaminergic pathways in the brain","author":"Iversen","year":"1982"},{"key":"10.1016\/j.ejps.2016.07.009_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1476-5381.1979.tb07846.x","article-title":"Effects of substance P injected into the substantia nigra","volume":"65","author":"James","year":"1979","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0079-6123(08)63824-8","article-title":"Descending noradrenergic influences on pain","volume":"88","author":"Jones","year":"1991","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cne.903540208","article-title":"Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, mu-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors","volume":"354","author":"Kar","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0170","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/cmdc.201000077","article-title":"Recent advances in endomorphin engineering","volume":"5","author":"Keresztes","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0175","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.2174\/138161281942140105165646","article-title":"Hybrid opioid\/non-opioid ligands in pain research","volume":"19","author":"Kleczkowska","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2016.07.009_bb0180","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0196-9781(84)90017-2","article-title":"Vasopressin analgesia: specificity pf action and non-opioid effects","volume":"5","author":"Kordower","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2016.07.009_bb9005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence:implications for treatment.","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.ejps.2016.07.009_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1254\/jjp.31.315","article-title":"Algesiogenic and analgesic activities of synthetic substance P","volume":"31","author":"Kotani","year":"1981","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0190","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1073\/pnas.90.8.3564","article-title":"Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level","volume":"90","author":"Kream","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.07.009_bb0195","article-title":"Synthesis and pharmacological analysis of a morphine\/substance P chimeric molecule with full analgesic potency in morphine-tolerant rats","volume":"13","author":"Kream","year":"2007","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejps.2016.07.009_bb0200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3565(25)21174-0","article-title":"The substance P amino-terminal metabolite substance P (1\u20137), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice","volume":"279","author":"Kreeger","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0091-3057(77)90226-X","article-title":"Barrel rotation induced by vasopressin and related peptides in rats","volume":"7","author":"Kruse","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2016.07.009_bb0215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3171\/jns.2004.101.4.0641","article-title":"Alpha2-adrenergic receptor subtype specificity of intrathecally administered tizanidine used for analgesia for neuropathic pain","volume":"101","author":"Leiphart","year":"2004","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2016.07.009_bb0220","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0006-291X(81)90266-7","article-title":"Analgesic effect of antagonists of substance P","volume":"103","author":"Lembeck","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2016.07.009_bb0225","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1002\/ange.201001898","article-title":"NMR-based protein potentials","volume":"122","author":"Li","year":"2010","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0230","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1073\/pnas.1108903108","article-title":"An antinociceptive role for substance P in acid-induced chronic muscle pain","volume":"109","author":"Lin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.07.009_bb0235","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-107-6-875","article-title":"NIH Conference. Alcohol withdrawal and noradrenergic function","volume":"107","author":"Linnoila","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2016.07.009_bb0240","first-page":"25","article-title":"Bifunctional pharmacophores. Biological activities of the peptide analog containing both casomorphine-like and substance P antagonist-like active elements","volume":"44","author":"Lipkowski","year":"1992","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.ejps.2016.07.009_bb0245","series-title":"Handbook of Biologically Active Peptides","first-page":"1373","article-title":"Opioid-substance P chimeric peptides","author":"Lipkowski","year":"2006"},{"key":"10.1016\/j.ejps.2016.07.009_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-4328(83)90011-6","article-title":"Korsakoff's psychosis: noradrenergic systems and cognitive impairment","volume":"9","author":"Mair","year":"1983","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0255","first-page":"6","article-title":"Neurobiology of substance P and the NK1 receptor","volume":"63","author":"Mantyh","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejps.2016.07.009_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/107156998819565974","article-title":"Dual functional interactions of substance P and opioids in nociceptive transmission: review and reconciliation","volume":"3","author":"Maszczynska","year":"1998","journal-title":"Analgesia"},{"key":"10.1016\/j.ejps.2016.07.009_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0167-0115(87)90281-3","article-title":"The effects of substance P, histamine and histamine antagonists on somatostatin and gastrin release from the isolated perfused rat stomach","volume":"19","author":"McIntosh","year":"1987","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejps.2016.07.009_bb0270","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-3565(25)38933-0","article-title":"An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P","volume":"268","author":"Mousseau","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0275","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2174\/092986711795496746","article-title":"NK-1 receptor antagonists: a new paradigm in pharmacological therapy","volume":"18","author":"Mu\u00f1oz","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0280","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/35012069","article-title":"Rewarding effects of opiates are absent in mice lacking the receptor for substance P","volume":"405","author":"Murtra","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2016.07.009_bb0285","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.92.13.6205","article-title":"Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4)","volume":"92","author":"Nagalla","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.07.009_bb0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(88)90296-8","article-title":"Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances","volume":"146","author":"Nakamura","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0295","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0024-3205(67)90157-9","article-title":"A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain","volume":"6","author":"Noble","year":"1967","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0306-4522(91)90089-7","article-title":"Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception","volume":"44","author":"Pertovaara","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2016.07.009_bb0305","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.bmc.2014.10.022","article-title":"Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine Bioorg","volume":"22","author":"Piekielna","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0310","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pharmthera.2006.04.010","article-title":"Inhibitory effect of somatostatin on inflammation and nociception","volume":"112","author":"Pinter","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0315","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cne.21793","article-title":"Participation of mu-opioid, GABA(B), and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: implications for descending modulation of nociceptive transmission","volume":"510","author":"Pinto","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0320","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0006-3495(98)77552-6","article-title":"Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints","volume":"75","author":"Pogozheva","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2016.07.009_bb0325","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0079-6123(08)62802-2","article-title":"Pharmacologic evidence for the modulation of nociception by noradrenergic neurons","volume":"77","author":"Proudfit","year":"1988","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0330","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0335","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(94)90698-X","article-title":"Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice","volume":"651","author":"Ravard","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0340","first-page":"147","article-title":"Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects","volume":"71","author":"Redmond","year":"1981","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb9010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1213\/00000539-199901000-00026","article-title":"The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat.","volume":"88","author":"Reimann","year":"1999","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejps.2016.07.009_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/0929867023371445","article-title":"[Dmt1]DALDA is highly selective and potent at mu opioid receptors but is not-cross tolernt with systemic morphine","volume":"9","author":"Riba","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0031-9384(69)90028-6","article-title":"Improved polyethylene cannulation techniques","volume":"4","author":"Robinson","year":"1969","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejps.2016.07.009_bb0355","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2003.11.060","article-title":"Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration","volume":"1001","author":"Ros\u00e9n","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0360","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1096\/fj.06-7793com","article-title":"Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers","volume":"21","author":"Rozenfeld","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2016.07.009_bb0365","first-page":"E124","article-title":"Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue","volume":"276","author":"Samii","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ejps.2016.07.009_bb0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2006.03.082","article-title":"Analgesic effects of somatostatin sst-4 receptor selective agonist J-2156 in acute and chronic pain","volume":"539","author":"Sandor","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifuncuntcional opioid peptides","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0380","first-page":"53","article-title":"Peripheral antinociceptive effect of an extremely mu-selective polar dermorphin analog (DALDA)","volume":"328","author":"Schiller","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcp.1041630110","article-title":"Substance P-related antagonists inhibit vasopressin and bombesin but not 5\u2033-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells","volume":"163","author":"Seckl","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0390","first-page":"364","article-title":"Antinociceptive and respiratory effects of intrathecal H-Tyr-d-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA","volume":"297","author":"Shimoyama","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2016.07.009_bb0395","series-title":"Molecular and Celular Aspects of Drug Addictions","first-page":"92","article-title":"Bradykinin and pain","author":"Snyder","year":"1989"},{"key":"10.1016\/j.ejps.2016.07.009_bb0400","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1073\/pnas.85.9.3245","article-title":"Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions","volume":"85","author":"Steranka","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.07.009_bb0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(95)00940-R","article-title":"Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist","volume":"700","author":"Stoessl","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb0410","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/0006-2952(70)90012-2","article-title":"p-Chloroamphetamine, temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine","volume":"19","author":"Strada","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0415","first-page":"57","article-title":"In vivo pharmacokinetics of selective \u03bc-opioid peptide agonists","volume":"298","author":"Szeto","year":"2001","journal-title":"J. Pharmacol. Exper. Therap."},{"key":"10.1016\/j.ejps.2016.07.009_bb0420","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0028-3908(83)90052-7","article-title":"Substance P stimulates the release of Met5-enkephalin-Arg6-Phe7 and Met5-enkephalin from rat spinal cord","volume":"22","author":"Tang","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2016.07.009_bb0425","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/jm7010222","article-title":"Endomorphin-2 with a beta-turn backbone constraint retains the potent mu-opioid receptor agonist properties","volume":"51","author":"T\u00f6mb\u00f6ly","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0430","first-page":"848","article-title":"Modulation by u-opioid agonists of guanosine-5\u2032-0-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SYSY cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mel. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0435","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0440","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1023\/A:1014359000606","article-title":"Dermorphins are natural opioids with a unique primary structure that determines their biological specificity","volume":"29","author":"Usenko","year":"2002","journal-title":"Biol. Bull. Rus. Acad. Sci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0445","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(88)90102-1","article-title":"Grooming behavior induced by P substance","volume":"154","author":"Van Wimersma Greidanus","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0450","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(87)90380-3","article-title":"Excessive grooming induced by somatostatin or ist analog SMS 201-995","volume":"144","author":"Van Wimersma Greidanus","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.07.009_bb0455","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1016\/j.bmc.2012.09.003","article-title":"Synthesis, biological activity and structure-activity relationship of endomorphin1\/substance P derivatives","volume":"20","author":"Varamini","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2016.07.009_bb0460","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0196-9781(89)90007-7","article-title":"Comparative studies of somatostatin 1\u20134 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats","volume":"10","author":"V\u00e9csei","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2016.07.009_bb0465","first-page":"520","article-title":"New tricks for an old slug: descending serotonergic system in pain","volume":"64","author":"Wei","year":"2012","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.ejps.2016.07.009_bb0470","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.1988.tb38608.x","article-title":"Pharmacological studies of grooming and scratching behavior elicited by spinal substance P and excitatory amino acids","volume":"525","author":"Wilcox","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejps.2016.07.009_bb0475","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(86)90719-5","article-title":"Barrel rotation evoked by intracerebroventricular vasopressin injections in concious rats. II. Visual\/vestibular interactions and efficacy of antiseizure drugs","volume":"365","author":"Wurpel","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2016.07.009_bb9020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1399-6576.1997.tb04623.x","article-title":"Pharmacology and mechanisms of opioid analgesic activity.","volume":"41","author":"Yaksh","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejps.2016.07.009_bb0480","first-page":"195","article-title":"Substance P: transmitter of nociception (minireview)","volume":"34","author":"Zubrzycka","year":"2000","journal-title":"Endocr. Regul."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716302639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716302639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:40:30Z","timestamp":1749001230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716302639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":99,"alternative-id":["S0928098716302639"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.07.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological evaluation and molecular docking studies of AA3052, a compound containing a \u03bc-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu-NH2, a substance P analogue","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}